BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors
Clinical trial NCT05935098 · TERMINATED
Trial details
- NCT number
- NCT05935098
- Sponsor
- BeiGene
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-21
- Primary completion
- 2026-01-27
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.